Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, will present the results from two Phase I clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback